Last reviewed · How we verify
Zoladex LA
At a glance
| Generic name | Zoladex LA |
|---|---|
| Also known as | Goserelin acetate 10.8 mg |
| Sponsor | Cancer Research Antwerp |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (PHASE2, PHASE3)
- GP Extended Action Triptorelin (PHASE4)
- Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy (PHASE3)
- Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |